Recommending that children be switched from the live attenuated influenza vaccine, which is available as a nasal spray, to an injectable vaccine has not discouraged patients from getting the vaccine, according to a recent analysis of Oregon’s immunization registry. Highlights include:
- The Advisory Committee on Immunization Practices stopped recommending the nasal spray before the 2016-2017 flu season began.
- Despite the change in policy, vaccination rates among children ages 2 to 17 years remained unchanged between 2015-2016 and 2016-2017.
- Children between the ages of 3 and 10 years who had a previous injectable vaccine were slightly more likely to have another injectable when they returned for their 2016-2017 vaccine, when compared to children with a previous nasal spray vaccine.
- Children between the ages of 11 and 17 years were 1.08 times more likely to return for a second injectable vaccine.
Robison SG, Dunn AG, Richards DL, Leman RF. Changes in influenza vaccination rates after withdrawal of live vaccine. [Published online ahead of print November 1, 2017]. Pediatrics. doi:10.1542/peds.2017-0516.
Must Reads in Vaccines
Vaccination for Prevention of Herpes Zoster, Ann Intern Med; ePub 2019 Feb 19; Prosser, et al